Crossmark

High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis

Crossref DOI link: https://doi.org/10.1186/s12879-018-3460-7

Published Online: 2018-12-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Hua-Zhen

Wang, Rui-Ying

Wang, Xuan

Jiang, Ying-Kui

Zhou, Ling-Hong

Cheng, Jia-Hui

Huang, Li-Ping

Harrison, Thomas Stephen

Zhu, Li-Ping
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 16 November 2017

Accepted: 31 October 2018

First Online: 12 December 2018

Ethics approval and consent to participate

: This study was reviewed and approved by the local medical Ethics Committee of Huashan Hospital, Fudan University, Shanghai, China. As this is a retrospective study, data was obtained through medical records and analyzed anonymously, and therefore informed consent of the participants was not required.

: Not applicable.

: TSH reports an investigator award and honoraria from Gilead Sciences, advisory board fees from Viamet, gift of tests for research from Immuno-Mycologics, and honoraria from Pfizer. All authors declare no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.